Pfizer assures that the distribution of its vaccine in the EU will begin “immediately”

Shipment of the COVID-19 vaccine developed by Pfizer and BioNTech will begin “immediately”, with “two containers initially” to each country of the European Union (EU), so that they can start vaccination on the same dates, sources from the US company informed Efe on Tuesday.

“The shipment will start immediately and each country will receive two containers initially, so that all Member States can receive the doses the same day during the holidays“Christmas, a Pfizer spokeswoman in Spain told Efe.

Regarding the SARS-CoV-2 mutation, the source of the pharmaceutical company stated that the new variant of the virus “does not affect the launch of the vaccine”, which has the ability to “neutralize multiple mutant strains”.

“To date, we have found consistent coverage of all strains tested,” said the source of the company, which, together with BioNTech, is “generating data on how well the sera of people immunized with (the vaccine) BNT162b2 can neutralize new UK strain. “

In a statement, the general manager of Pfizer’s factory in Puurs (Belgian town where the vaccine is produced for European supply), Luc Van Steenwinkel, said “proud and grateful” that “the first doses of vaccines, made in Puurs, can now go out to so many European countries”.

After the European Medicines Agency (EMA) guaranteed yesterday, Monday, the safety and efficacy of the vaccine, the European Commission (EC) authorized its use so that next Sunday, December 27 start the vaccination campaigns against the virus in the 27 EU countries.

The president of the EC, Úrsula von der Leyen, indicated this Monday in a brief appearance after giving the go-ahead to the commercialization of the antidote that these campaigns will be launched “at the same time and under the same conditions” in all European countries.

“The lasting way out of this crisis is vaccination, which begins in a few days throughout the European Union. Until then, let’s be careful“Von der Leyen tweeted today.

The long-awaited vaccine leaves Puurs, a Belgian municipality with an agricultural tradition that is home to several pharmaceutical companies, including the North American Pfizer, whose plant has the capacity to produce 400 million doses of vaccines per year.

Its mayor, Koen van Der Heuvel, highlighted in a recent interview with Efe that the pharmaceutical company opted for this town to manufacture the drug due to its geographical location, since Puurs has direct access to Zaventem airport and the port of Antwerp.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.